BAYRY's experimental Parkinson's disease drug continues to show a favorable safety profile in all 12 participants in the ...
LOBO READ THE FULL LOBO RESEARCH REPORT Pre-market open on 9/30/24, LOBO EV (NASDAQ:LOBO) reported 1H24 earnings results. For the first six months of 2024, LOBO reported a net loss of $0.3 million, or ...
A rate cut ahead of the holiday season and cooling inflation is going to help consumer discretionary stocks like AOUT, CNK, ...